These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 12393881

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway.
    Akool el-S, Doller A, Müller R, Gutwein P, Xin C, Huwiler A, Pfeilschifter J, Eberhardt W.
    J Biol Chem; 2005 Nov 25; 280(47):39403-16. PubMed ID: 16183640
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
    Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P.
    Mol Cell; 2003 Oct 25; 12(4):817-28. PubMed ID: 14580334
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantification of transforming growth factor beta1 (TGFbeta1) mRNA expression in mouse preimplantation embryos and determination of TGFbeta receptor (type I and type II) expression in mouse embryos and reproductive tract.
    Chow JF, Lee KF, Chan ST, Yeung WS.
    Mol Hum Reprod; 2001 Nov 25; 7(11):1047-56. PubMed ID: 11675471
    [Abstract] [Full Text] [Related]

  • 9. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S, Brattain MG.
    J Biol Chem; 2004 Jul 30; 279(31):32620-5. PubMed ID: 15155736
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Functional antagonism between activin and osteogenic protein-1 in human embryonal carcinoma cells.
    Piek E, Afrakhte M, Sampath K, van Zoelen EJ, Heldin CH, ten Dijke P.
    J Cell Physiol; 1999 Aug 30; 180(2):141-9. PubMed ID: 10395283
    [Abstract] [Full Text] [Related]

  • 13. Differential requirement for type I and type II transforming growth factor beta receptor kinase activity in ligand-mediated receptor endocytosis.
    Anders RA, Doré JJ, Arline SL, Garamszegi N, Leof EB.
    J Biol Chem; 1998 Sep 04; 273(36):23118-25. PubMed ID: 9722540
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structural basis for specificity of TGFβ family receptor small molecule inhibitors.
    Ogunjimi AA, Zeqiraj E, Ceccarelli DF, Sicheri F, Wrana JL, David L.
    Cell Signal; 2012 Feb 04; 24(2):476-483. PubMed ID: 21983015
    [Abstract] [Full Text] [Related]

  • 16. A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy.
    Watkins SJ, Jonker L, Arthur HM.
    Cardiovasc Res; 2006 Feb 01; 69(2):432-9. PubMed ID: 16360132
    [Abstract] [Full Text] [Related]

  • 17. The essential similarity of TGFbeta and activin receptor transcriptional responses in cancer cells.
    Ryu B, Kern SE.
    Cancer Biol Ther; 2003 Feb 01; 2(2):164-70. PubMed ID: 12750556
    [Abstract] [Full Text] [Related]

  • 18. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
    Liu X, Nagarajan RP, Vale W, Chen Y.
    FEBS Lett; 2002 May 22; 519(1-3):93-8. PubMed ID: 12023024
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A, Speletas M, Leandersson K, Ivars F, Sideras P.
    Int Immunol; 2003 Dec 22; 15(12):1401-14. PubMed ID: 14645149
    [Abstract] [Full Text] [Related]

  • 20. The role of transforming growth factor-beta and its receptors in human prostate smooth muscle cell fibronectin production.
    Butter S, Laping NJ, Pullen M, Grygielko E, Olson B, Brooks DP.
    Eur J Pharmacol; 2001 Jun 22; 422(1-3):47-52. PubMed ID: 11430912
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.